SOURCE: Novo Nordisk A/S

January 19, 2011 18:11 ET

Novo Nordisk intends to appeal adverse ruling in Prandin® (repaglinide) patent case

BAGSVæRD, DENMARK--(Marketwire - January 19, 2011) -

Company Announcement no 2 2011:

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via Thomson Reuters ONE


Contact Information